- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kuros Biosciences AG (KURN)
Kuros Biosciences AG stock price live, this page displays SIX KURN stock exchange data. View the KURN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kuros Biosciences AG real time stock price chart below.
What Is the Kuros Biosciences AG Stock Price Today?
The Kuros Biosciences AG stock price today is 21.520.
What Is the Stock Symbol for Kuros Biosciences AG?
The stock ticker symbol for Kuros Biosciences AG is KURN.
Is KURN the Same as $KURN?
$KURN is a common way to refer to the Kuros Biosciences AG ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Kuros Biosciences AG Trade On?
Kuros Biosciences AG is listed and trades on the Switzerland stock exchange.
Is Kuros Biosciences AG a Good Stock to Buy?
Determining whether Kuros Biosciences AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Kuros Biosciences AG share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KURN quote. (ISIN: CH0325814116)
What Is the Kuros Biosciences AG Stock Price Today?
The Kuros Biosciences AG stock price today is 21.520.
What Is the Stock Symbol for Kuros Biosciences AG?
The stock ticker symbol for Kuros Biosciences AG is KURN.
Is KURN the Same as $KURN?
$KURN is a common way to refer to the Kuros Biosciences AG ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Kuros Biosciences AG Trade On?
Kuros Biosciences AG is listed and trades on the Switzerland stock exchange.
Is Kuros Biosciences AG a Good Stock to Buy?
Determining whether Kuros Biosciences AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Kuros Biosciences AG share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KURN quote. (ISIN: CH0325814116)
Currency in CHF
21.520
-0.940(-4.19%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.520
22.180
52 wk Range
17.690
34.200
KURN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.52022.180
52 wk Range
17.69034.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
KURN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
33.916
Upside
+57.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 33.916
(+57.60% Upside)
Kuros Biosciences AG Earnings Call Summary for Q2/2026
- Kuros posted H1 2026 sales of CHF 92.4M, up 45% YoY, with adjusted EBITDA of CHF 12.5M and net profit of CHF 4.4M vs. CHF 2M loss prior year.
- Company maintained ~90% gross margin through scale and cost control; revenue grew 566% since H1 2023 while fixed costs rose only 271%.
- Management guided FY 2026 revenue growth of ~35%, below H1 pace; expects H2 margin pressure from new Georgia manufacturing ramp-up costs.
- Long-term plan targets CHF 300-330M revenue by 2028 with 20%+ EBITDA margin; new products include MagnetOs MIS Gen 2 and resorbable bone filler.
- U.S. market represents 95% of revenue; company aims to grow international sales to 5-10% medium-term despite Q2 regulatory headwinds abroad.
Last Updated: 08/13/2026, 10:32 AM
Read Full TranscriptKuros Biosciences investor slides for Q2/2026
Last Update: Aug 13, 2026
See full investor slides
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
0.11 / --
Revenue / Forecast
92.35M / --
Compare KURN to Peers and Sector
Metrics to compare | KURN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKURNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 125.0x | 17.6x | −0.3x | |
PEG Ratio | 0.52 | 0.22 | 0.00 | |
Price / Book | 13.2x | 2.6x | 2.6x | |
Price / LTM Sales | 6.4x | 2.1x | 3.1x | |
Upside (Analyst Target) | 46.2% | 4.1% | 47.6% | |
Fair Value Upside | Unlock | 14.8% | 5.6% | Unlock |
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Kuros Biosciences (KURN) Stock Price Today?
The Kuros Biosciences stock price today is 21.520 CHF.
What Stock Exchange Does Kuros Biosciences Trade On?
Kuros Biosciences is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Kuros Biosciences?
The stock symbol for Kuros Biosciences is "KURN."
What Is the Kuros Biosciences Market Cap?
As of today, Kuros Biosciences market cap is 891.030M CHF.
What Is Kuros Biosciences's Earnings Per Share (TTM)?
The Kuros Biosciences EPS (TTM) is 0.216.
When Is the Next Kuros Biosciences Earnings Date?
Kuros Biosciences will release its next earnings report on Oct 16, 2025.
From a Technical Analysis Perspective, Is KURN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kuros Biosciences Stock Split?
Kuros Biosciences has split 8 times.
How Many Employees Does Kuros Biosciences Have?
Kuros Biosciences has 178 employees.
What is the current trading status of Kuros Biosciences (KURN)?
As of Aug 21, 2026, Kuros Biosciences (KURN) is trading at a price of 21.520 CHF, with a previous close of 22.460 CHF. The stock has fluctuated within a day range of 21.520 CHF to 22.180 CHF, while its 52-week range spans from 17.690 CHF to 34.200 CHF.
What Is Kuros Biosciences (KURN) Price Target According to Analysts?
The average 12-month price target for Kuros Biosciences is 33.916 CHF, with a high estimate of 38 CHF and a low estimate of 32 CHF. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +57.60% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.